在耐火性自身免疫性肌痛性骨髓质疏松症的efgartigimod
Linda Remijn-Nelissen1, Martijn R Tannemaat1, Annabel M Ruiter1
1Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Muscle & nerve
|June 20, 2024
概括
在超过一半的患者中,efgartigimod有效治疗了耐火性肌痛性肌痛症 (MG),减少了对其他药物的需求. 与之前的试验相比,注意到了剂量频率的调整.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓灰质炎 (MG) 是一种罕见的自身免疫性疾病,影响神经肌肉结节.
- 新生儿Fc受体抑制剂Efgartigimod为MG提供了一种新的治疗方法.
- 耐药性MG病例在治疗疗效方面存在持续的挑战.
研究的目的:
- 评估efgartigimod在耐火性MG患者的短期和长期疗效.
- 用标准化MG评估工具评估临床结果.
主要方法:
- 对16名具有耐火性自身免疫性乙胆受体MG的患者进行了回顾性队列研究.
- 在2021年1月至2023年3月期间接受efgartigimod治疗.
- 在MG-ADL,QMG,MGC和MG-QoL15r得分上收集的数据.
主要成果:
- 56%的患者在最后一次测量时显示出良好的结果.
- 到第4周,在MG-ADL,QMG和MGC得分中观察到临床上有意义的改善.
- 从基线到第4周,MG-QoL15r显著改善,长期维持.
- 大多数患者的同时服用药物 (普雷尼索隆,阿扎西奥普林,IVIg) 和血交换的需求减少.
结论:
- 埃夫加蒂格莫德在至少一半的耐火性MG患者中显示出有效性.
- 在80%的患者中,同时减少或停止药物治疗.
- 与ADAPT第三阶段试验相比,需要更高的剂量频率.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
01:15Myasthenia Gravis: Diagnostic Tests
764
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
764
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
01:28Disorders of the Skeletal Muscle
928
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
928